Search
- Feb 2, 2022
- 5 min
4D pharma announces positive data from Part A of its Phase I/II trial for the treatment of asthma
The global asthma therapeutics market is projected to reach $23.1 billion by 2023.
- Feb 1, 2022
- 2 min
Austria-based Ribbon Biolabs closes on financing for commercialization of DNA synthesis technology
Ribbon Biolabs is a synthetic biology company advancing a new technology for the automated synthesis of long DNA molecules.
- Jan 31, 2022
- 3 min
PrecisionLife closes on financing to advance its AI-led drug discovery for precision medicine
PrecisionLife is changing the way the world looks at predicting, preventing, and treating chronic disease.
- Jan 30, 2022
- 2 min
Enable Injections closes on financing to advance its subcutaneous drug delivery technology
enFuse® is a drug delivery technology designed to subcutaneously (SC) deliver large volumes of up to 50mL for a wide range of therapies...
- Jan 29, 2022
- 4 min
Fujifilm to acquire Atara Pharma's cell therapy manufacturing facility
Atara Biotherapeutics is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop therapies.